What is the 1 month CMT rate today?
I would like to know the current 1-month CMT rate. Could you please provide me with the latest information on this rate today?
What is the current 5 year CMT rate today?
The current 5-year CMT rate, referring to the 5-year survival rate after combined modality therapy for early-stage low-risk Hodgkin's Lymphoma, is reported to be high. Specifically, for patients with PET-2 negative results, the estimated 5-year progression-free survival (PFS) rate after CMT is 94.2%. This rate is significantly higher than the 86.7% PFS rate for patients treated with ABVD alone, indicating the efficacy of CMT in this patient population.